Phibro Animal Health Operating Income 2012-2025 | PAHC

Phibro Animal Health operating income from 2012 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Phibro Animal Health Annual Operating Income
(Millions of US $)
2024 $53
2023 $72
2022 $79
2021 $75
2020 $69
2019 $83
2018 $99
2017 $98
2016 $86
2015 $88
2014 $64
2013 $57
2012 $49
2011 $41
Phibro Animal Health Quarterly Operating Income
(Millions of US $)
2025-03-31 $34
2024-12-31 $26
2024-09-30 $18
2024-06-30 $18
2024-03-31 $20
2023-12-31 $16
2023-09-30 $-1
2023-06-30 $24
2023-03-31 $19
2022-12-31 $16
2022-09-30 $14
2022-06-30 $23
2022-03-31 $19
2021-12-31 $22
2021-09-30 $15
2021-06-30 $19
2021-03-31 $20
2020-12-31 $20
2020-09-30 $16
2020-06-30 $18
2020-03-31 $21
2019-12-31 $20
2019-09-30 $10
2019-06-30 $12
2019-03-31 $23
2018-12-31 $26
2018-09-30 $23
2018-06-30 $26
2018-03-31 $26
2017-12-31 $24
2017-09-30 $22
2017-06-30 $24
2017-03-31 $30
2016-12-31 $23
2016-09-30 $22
2016-06-30 $20
2016-03-31 $21
2015-12-31 $23
2015-09-30 $22
2015-06-30 $21
2015-03-31 $22
2014-12-31 $20
2014-09-30 $25
2014-06-30 $13
2014-03-31 $17
2013-12-31 $17
2013-09-30 $16
2013-06-30
2013-03-31 $14
2012-06-30
2011-06-30
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.133B $1.018B
Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. The company provides a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. In addition to animal health and mineral nutrition products, Phibro manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. Currently, Phibro focuses on regions where the majority of livestock production is consolidated in large commercial farms such as the U.S., Brazil, China, Russia, Mexico, Australia, Turkey, Israel, Canada and Europe.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.329B 28.06
Boston Scientific (BSX) United States $153.315B 38.38
Stryker (SYK) United States $149.550B 31.27
EssilorLuxottica (ESLOY) France $129.320B 0.00
Medtronic (MDT) Ireland $113.223B 16.05
Lonza Group Ag (LZAGY) Switzerland $50.710B 0.00
Haleon (HLN) United Kingdom $46.111B 26.31
ResMed (RMD) United States $37.519B 28.18
GE HealthCare Technologies (GEHC) United States $34.854B 16.55
Agilent Technologies (A) United States $34.275B 22.34
Terumo (TRUMY) Japan $25.791B 33.50
Koninklijke Philips (PHG) Netherlands $23.611B 16.57
Insulet (PODD) United States $21.226B 83.32
Zimmer Biomet Holdings (ZBH) United States $18.499B 11.88
Baxter (BAX) United States $15.975B 11.93
Smith & Nephew SNATS (SNN) United Kingdom $13.209B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.821B 23.74
Lantheus Holdings (LNTH) United States $5.509B 13.90
Prestige Consumer Healthcare (PBH) United States $3.962B 17.70
Perrigo (PRGO) Ireland $3.748B 9.50
Haemonetics (HAE) United States $3.663B 16.68
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.419B 28.41
ICU Medical (ICUI) United States $3.352B 24.72
QuidelOrtho (QDEL) United States $2.041B 14.04
LeMaitre Vascular (LMAT) United States $1.894B 42.35
AtriCure (ATRC) United States $1.554B 0.00
Acuren (TIC) United States $1.375B 0.00
AdaptHealth (AHCO) United States $1.264B 12.84
Green Thumb Industries (GTBIF) United States $1.169B 26.29
Neogen (NEOG) United States $1.135B 14.53
BioLife Solutions (BLFS) United States $1.081B 0.00
InMode (INMD) Israel $0.961B 9.69
Kestra Medical Technologies (KMTS) United States $0.783B 0.00
Owens & Minor (OMI) United States $0.718B 5.96
Maravai LifeSciences Holdings (MRVI) United States $0.675B 0.00
CeriBell (CBLL) United States $0.673B 0.00
Evolus (EOLS) United States $0.594B 0.00
Curaleaf Holdings (CURLF) Canada $0.551B 0.00
Valneva SE (VALN) France $0.494B 0.00
Tilray Brands (TLRY) Canada $0.488B 0.00
Capricor Therapeutics (CAPR) United States $0.458B 0.00
Surmodics (SRDX) United States $0.415B 0.00
VAREX IMAGING (VREX) United States $0.359B 13.21
Quanterix (QTRX) United States $0.346B 0.00
SNDL (SNDL) Canada $0.328B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.301B 0.00
Cerus (CERS) United States $0.298B 0.00
Viemed Healthcare (VMD) United States $0.280B 23.60
ZimVie (ZIMV) United States $0.279B 12.67
Sanuwave Health (SNWV) United States $0.271B 0.00
Sanara MedTech (SMTI) United States $0.266B 0.00
Aurora Cannabis (ACB) Canada $0.251B 74.50
Cresco Labs (CRLBF) United States $0.251B 0.00
Brainsway (BWAY) Israel $0.242B 64.00
Biote (BTMD) United States $0.229B 6.45
OraSure Technologies (OSUR) United States $0.229B 0.00
Canopy Growth (CGC) Canada $0.219B 0.00
High Tide (HITI) Canada $0.190B 0.00
Utah Medical Products (UTMD) United States $0.187B 15.21
TriSalus Life Sciences (TLSI) United States $0.185B 0.00
Organigram Global (OGI) Canada $0.185B 0.00
Verano Holdings (VRNOF) United States $0.182B 0.00
Omeros (OMER) United States $0.181B 0.00
Vireo Growth (VREOF) United States $0.150B 0.00
Exagen (XGN) United States $0.148B 0.00
FitLife Brands (FTLF) United States $0.128B 15.73
Jin Medical (ZJYL) China $0.100B 0.00
Fonar (FONR) United States $0.096B 12.33
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
MacroGenics (MGNX) United States $0.087B 0.00
TerrAscend (TSNDF) Canada $0.086B 0.00
Veru (VERU) United States $0.086B 0.00
Zynex (ZYXI) United States $0.081B 0.00
Apyx Medical (APYX) United States $0.081B 0.00
Quipt Home Medical (QIPT) United States $0.077B 0.00
Agape ATP (ATPC) $0.069B 0.00
InterCure (INCR) Israel $0.067B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
Jushi Holdings (JUSHF) United States $0.060B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
Nephros (NEPH) United States $0.042B 56.86
Modular Medical (MODD) United States $0.038B 0.00
United-Guardian (UG) United States $0.037B 12.81
Safety Shot (SHOT) United States $0.030B 0.00
Rockwell Medical (RMTI) United States $0.028B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
INLIF (INLF) $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Senestech (SNES) United States $0.011B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00